These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets. Suzuki M; Sugatani J; Ino M; Shimura M; Akiyama M; Yamazaki R; Suzuki Y; Miwa M Am J Physiol; 1998 Jan; 274(1):C47-57. PubMed ID: 9458712 [TBL] [Abstract][Full Text] [Related]
5. Platelet-aggregating effects of platelet-activating factor-like phospholipids formed by oxidation of phosphatidylcholines containing an sn-2-polyunsaturated fatty acyl group. Tanaka T; Iimori M; Tsukatani H; Tokumura A Biochim Biophys Acta; 1994 Jan; 1210(2):202-8. PubMed ID: 8280771 [TBL] [Abstract][Full Text] [Related]
6. An oxidized derivative of phosphatidylcholine is a substrate for the platelet-activating factor acetylhydrolase from human plasma. Stremler KE; Stafforini DM; Prescott SM; Zimmerman GA; McIntyre TM J Biol Chem; 1989 Apr; 264(10):5331-4. PubMed ID: 2494162 [TBL] [Abstract][Full Text] [Related]
7. Biological effects of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine in the human neutrophil. Triggiani M; Goldman DW; Chilton FH Biochim Biophys Acta; 1991 Jun; 1084(1):41-7. PubMed ID: 1647203 [TBL] [Abstract][Full Text] [Related]
8. Evidence that phospholipid oxidation products and/or platelet-activating factor play an important role in early atherogenesis : in vitro and In vivo inhibition by WEB 2086. Subbanagounder G; Leitinger N; Shih PT; Faull KF; Berliner JA Circ Res; 1999 Aug; 85(4):311-8. PubMed ID: 10455059 [TBL] [Abstract][Full Text] [Related]
9. 1-O-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine. A common source of platelet-activating factor and arachidonate in human polymorphonuclear leukocytes. Chilton FH; Ellis JM; Olson SC; Wykle RL J Biol Chem; 1984 Oct; 259(19):12014-9. PubMed ID: 6434535 [TBL] [Abstract][Full Text] [Related]
14. Monocyte binding to endothelial cells induced by oxidized phospholipids present in minimally oxidized low density lipoprotein is inhibited by a platelet activating factor receptor antagonist. Leitinger N; Watson AD; Faull KF; Fogelman AM; Berliner JA Adv Exp Med Biol; 1997; 433():379-82. PubMed ID: 9561175 [TBL] [Abstract][Full Text] [Related]
15. Hydrolysis of 1-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine, a common precursor of platelet-activating factor and eicosanoids, by human platelet phospholipase A2. Kramer RM; Jakubowski JA; Deykin D Biochim Biophys Acta; 1988 Apr; 959(3):269-79. PubMed ID: 3355850 [TBL] [Abstract][Full Text] [Related]
16. Platelet-activating factor contributes to acute lung leak in rats given interleukin-1 intratracheally. Lee YM; Hybertson BM; Cho HG; Terada LS; Cho O; Repine AJ; Repine JE Am J Physiol Lung Cell Mol Physiol; 2000 Jul; 279(1):L75-80. PubMed ID: 10893205 [TBL] [Abstract][Full Text] [Related]
17. Ether phospholipids as inhibitors of the arachidonoyl-CoA: 1-acyl-sn-glycero-3-phosphocholine acyltransferase in macrophages. Herrmann DB; Ferber E; Munder PG Biochim Biophys Acta; 1986 Mar; 876(1):28-35. PubMed ID: 3947667 [TBL] [Abstract][Full Text] [Related]
18. IL-1-induced adhesion of polymorphonuclear leukocytes to cultured human endothelial cells. Role of platelet-activating factor. Breviario F; Bertocchi F; Dejana E; Bussolino F J Immunol; 1988 Nov; 141(10):3391-7. PubMed ID: 3263425 [TBL] [Abstract][Full Text] [Related]